Overview

Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
This study will provide a direct comparison of 'continuous therapy' and 'intermittent therapy' with withdrawal and retreatment upon return of psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Etanercept